These compounds decreased the levels of the oncogenic Hsp90 client protein estrogen receptor α (ERα) in MCF-7 (5x, 89 and 104) and c-rapidly accelerated fibrosarcoma (c-Raf) in SK-N-MC (3) [49,50,51]. This evidence concerns the gene ESR1 and fibrosarcoma.